SAGINAW, Mich.--(BUSINESS WIRE)--Graminex® L.L.C., producer of Graminex® Non-Solvent Flower Pollen Extracts™, receives Health Canada Approval under the Natural and Non-prescription Health Products Directorate (NNHPD) for its PollenBerry® Flower Pollen Extract™. PollenBerry® is a proprietary formulation containing Graminex® G60® Flower Pollen Extract™ and Cranberry Powder.
Health Canada’s certification guarantees that Graminex Products meet the highest quality standards according to the guidelines of Health Canada’s Health Products and Food Branch’s Mandate. The mandated guidelines take an integrated approach to managing the risks and benefits in regards to supplements and health food, safeguarding the consumer against inferior products.
“With the addition of PollenBerry®, Graminex® now has three finished goods approved by Health Canada’s NNHPD with the associated NPN numbers. We are happy to offer this newest product to our customers,” stated Justin E. Ritter, Regulatory Affairs.
PollenBerry® has been approved for use as a traditional and herbal medicine with Graminex’s newest NPN license. The recommended use for PollenBerry® approved under this NPN is to help prevent (recurrent) urinary tract infections (UTIs) in women. A secondary claim was approved to help prevent (recurrent) urinary tract infections, which may increase in frequency/incidence after/as a result of menopause in women.
About Graminex® L.L.C.
Graminex® L.L.C. is the leading producer of natural and solvent free Graminex® Flower Pollen Extract™. Graminex® directly owns and manages more than 6,500 acres of farmland in Northwest Ohio to meet its customer’s needs. Graminex’s® active ingredients are grown and processed for the dietary supplement, nutraceutical, pharmaceutical, food and skin care industries. Graminex® markets its own line of dietary supplements, focusing on prostate care, urinary care, menopausal support, and skin care. Partnered with its distributors, retailers and manufacturers, Graminex® non-solvent products are sold in more than 44 countries on six continents.
For further information please contact Graminex® L.L.C. Public Relations, Colleen May at (419) 278-1023 or by e-mail at info@graminex.com. You may also visit www.graminex.com.
